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AbstrAct
Objectives The relationship between sexual practices, 
identity and role among Latino men who have sex 
with men (MSM) and HIV risk is the subject of ongoing 
investigation but less is known about how these aspects 
of sexuality relate to human papilloma-virus (HPV), an 
independent risk factor for HIV. This observational study 
investigated the relationship between HPV and sexual 
practices, identity and role as well as other sexually 
transmitted infection (STI)/HIV risk factors among HIV-
negative heterosexually and homosexually identified 
Peruvian MSM.
setting Community-based clinic for MSM in Lima, Peru.
Participants 756 subjects were screened based on 
inclusion criteria of: born anatomically male; age ≥18 
years; had any anal intercourse with a man during the 
previous 12 months; residing in metropolitan Lima; HIV 
negative; willing to commit to twice-yearly clinic visits for 
24 months; had not participated in an HIV or HPV vaccine 
study. 600/756 participants met the inclusion criteria 
and were enrolled, of whom 48% (284) identified as 
homosexual and 10% (57) as heterosexual, the basis of 
the analyses performed.
results Compared with homosexually identified MSM, 
heterosexually identified MSM had completed fewer years 
of formal education and were less likely to have: anogenital 
HPV or visible anal warts; given oral sex to a man; or used 
a condom with their most recent female sexual partner 
(all p<0.05). Conversely, heterosexually identified MSM 
were more likely to have: visible penile warts; used a 
condom during last anal intercourse; smoked cigarettes; 
had transactional sex; and used drugs during sex in the 
previous month (all p<0.01). There was no difference found 
between heterosexually and homosexually identified MSM 
by syphilis or high-risk HPV prevalence.
conclusions HPV burden, wart type (penile vs anal) 
and select HIV/STI risk behaviours differed between 
heterosexually and homosexually identified Peruvian 
MSM. Understanding the implications of these differences 
can lead to tailored HIV/STI prevention interventions for 
heterosexually identified MSM.
trial registration number NCT01387412.
IntrOductIOn
Understanding the relationship between 
reported anal sex practices (ie, insertive 
only, receptive only, or insertive and recep-
tive) and HIV transmission among Latino 
men who have sex with men (MSM) can 
help predict and prevent new infections.1–4 
Increasingly, however, research has expanded 
to include sexual practices and Latino MSM’s 
sexual identities (ie, homosexual, bisexual or 
heterosexual) and roles (ie, activo, pasivo or 
moderno/versatil) to better understand HIV 
transmission dynamics in this population.5 6 
Sexual identity refers to one’s self-identifica-
tion as homosexual, bisexual or heterosexual 
while sexual role (activo, pasivo or moderno/
versatil) is a self-identifier that maps onto 
traditional, gender-based norms used to 
conceptualise sexual relationships between 
Latino MSM.7 8 But while the HIV preven-
tion field is adopting a more complex view 
of Latino MSM sexuality, less is known about 
how Latino MSM’s sexual practices, identity 
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strengths and limitations of this study
 ► This is the first study to examine sexual identity as it 
relates to human papillomavirus.
 ► Data collection included both subjective (knowledge, 
behavioural) measures and objective (DNA, physical 
exam) measures.
 ► Due to non-random sampling and a cross-sectional 
design, causality cannot be established.
 ► The small sample size precluded more advanced 
statistical procedures.
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and roles relate to other sexually transmitted infections 
(STI).
The presence of STIs in MSM, particularly ulcerative 
diseases such as syphilis and the herpes simplex-2 virus 
but also anal warts (caused by human papillomavirus or 
HPV), is independently associated with HIV infection.9–13 
HPV is unique among STIs, however, in two important 
ways. First, it is the most common STI worldwide (an 
estimated 630 million people are infected globally14) 
and disproportionally affects MSM, with prevalences esti-
mated at 61% in HIV-negative MSM and 93% in HIV-pos-
itive MSM15 compared with ≤50% in men who have sex 
exclusively with women.16 Second, HPV is the only STI 
for which a safe and effective vaccine  that can prevent 
both anogenital warts and many of the associated cancers 
exists.17 Yet, even in the USA, where the HPV vaccine is 
recommended for MSM up to age 26, uptake lags far 
behind other populations for whom it is indicated.18
One contributing factor for low HPV vaccination rates 
among MSM is that vaccination uptake is greatly mediated 
by medical provider recommendation19 and is more likely 
when men disclose being gay or bisexual to their doctor.18 
But MSM, particularly those identifying as heterosexual, 
may be reluctant to share information about sex with 
other men with medical providers, fearing stigmatisa-
tion and discrimination.20 21 For example, in a qualitative 
analysis of HPV knowledge, attitudes and treatment expe-
riences among Peruvian MSM, an emergent theme specif-
ically among participants self-identifying as ‘not gay’ was 
that genital warts were associated with ‘having AIDS’ or 
‘being gay’.22
HPV vaccination in Peru presently remains indicated 
only for adolescent girls,23 and while all boys would ideally 
be offered vaccination as well, MSM—especially the 
young or sexually naïve—could also benefit. One study of 
105 MSM from an inner-city STI clinic in Lima found that 
77.1% were infected with anogenital HPV and 43% were 
infected with a carcinogenic type; high-risk HPV type 
infection was associated with sex work, HIV status and 
rectal chlamydial or gonorrhoeal infection.24 Another 
study of HPV prevalence among 200 Peruvian MSM 
found the seroprevalence of HPV types 6/11/16/18—for 
which the quadrivalent HPV vaccine confers protection—
was 64.3% and 93.8% for HIV-negative and HIV-positive 
MSM, respectively.25 While both studies included infor-
mation related to sexual practices, identity and roles, the 
analyses conducted do not allow side-by-side compari-
sons of these factors and HPV, information which could 
inform HPV surveillance, prevention and treatment for 
Latino MSM.
In the present study, we aimed to extend the under-
standing of HPV in Latino MSM by examining sexual 
identity and role as they relate to HPV prevalence, knowl-
edge, burden and genital wart location, and other STI 
and HIV risk factors. Since heterosexually self-identified 
MSM face unique challenges for HIV/STI prevention 
and treatment compared with other MSM, we focused 
specifically on this population (ie, excluding transgender 
women and MSM who self-identified as bisexual) as 
compared with homosexually identified MSM.
MethOds
We conducted a cross-sectional analysis of data collected 
at the baseline visit from a cohort study investigating 
the role of anogenital warts on HIV acquisition among 
a convenience sample of 600 HIV-uninfected MSM 
and transgender women in Lima, Peru (described in 
detail elsewhere26). Briefly, between February 2012 and 
February 2013, study participants were recruited at a 
community-based health centre for MSM and trans-
gender people, as well as at bars, clubs, volleyball courts, 
via social media and by snowball sampling. Eligibility 
criteria for participation were: born anatomically male; 
at least 18 years old; reported any anal intercourse with 
a man during the previous 12 months; residing in metro-
politan Lima; tested HIV negative at enrolment; willing 
to commit to twice-yearly clinic visits for 24 months; 
and had not previously participated in an HIV or HPV 
vaccine study. HIV status was determined using the Deter-
mine HIV-1/2 Combo Ag/Ab test (Alere Medical, Japan) 
and confirmed by indirect immunofluorescence assay 
(in-house test, Peruvian National Institute of Health). 
Enrolled participants were screened for past or active 
syphilis using the Determine TP test (Alere Medical) 
and completed a 20 min, computer-assisted self-interview. 
Participants underwent a physical examination by a study 
clinician who noted circumcision status and the pres-
ence of visible anogenital warts; appropriate treatment 
and referrals were made as necessary. Using prewetted 
Dacron swabs, genital specimens were collected from the 
coronal sulcus/glans penis, penile shaft, scrotum and 
anus, combined into one sample per participant, stored 
at −80°C, and sent to the Moffitt Cancer Center (USA) 
for DNA extraction using the QIAamp Media MDx Kit 
(Qiagen, Germantown, MD) followed by PCR and HPV 
genotyping. The samples were combined in this way to 
increase cost-effectiveness of the HPV genotyping. The 
Linear Array Assay (Roche Diagnostics, Indianapolis, IN) 
was used for detection of 37 HPV genotypes classified as 
high risk (oncogenic; HPV 16, 18, 31, 33, 35, 39, 45, 51, 
52, 56, 58, 59 and 68) or low risk (non-oncogenic; HPV 6, 
11, 26, 40, 42, 53, 54, 55, 61, 62, 64, 66, 67, 69, 70, 71, 72, 
73, 81, 82, 82 subtype IS39, 83, 84 and 89).
Participants were provided approximately US$3 for 
transportation to and from the study site as well as 
condoms, lubricant and a small gift (eg, water bottle, 
keychain). All participants provided informed consent 
before study participation.
Measures
Data collected in the self-administered survey included: 
age (years); education level (at least secondary or higher 
than secondary); sexual identity (homosexual or gay; 
bisexual; heterosexual; transgender; other); sexual role 
during anal intercourse with men (ie, activo, pasivo, 
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moderno); transactional sex (ie, exchange of money/items 
of value for sex, ever, yes/no); sex and concomitant drug 
and alcohol use (past month, yes/no); cigarette use (ever, 
yes/no); age at first anal intercourse (years); oral sex 
(given) with a man (ever, yes/no); condom use during 
anal intercourse (last, yes/no); HPV knowledge (‘Have 
you ever heard of HPV or human papilloma virus prior to 
participating in this study?’, yes/no).
data analysis
Beginning with bivariate analysis, we examined all vari-
ables only among heterosexually identified and homosex-
ually identified MSM, after which χ2 tests were conducted 
to compare the frequency of each variable for both 
groups. Next, using a generalised linear model, we exam-
ined the adjusted association of the biological HPV-re-
lated variables (ie, anogenital HPV prevalence, anal and 
penile wart presence and high-risk HPV prevalence) with 
select sample characteristics, including sexual identity. 
Only those variables that were statistically significant in 
the bivariate analysis were included in the models. All 
analyses were conducted using Stata V.12.0 (StataCorp, 
College Station, TX).
results
Of 756 subjects screened, 600 were determined to be 
HIV negative by rapid test and enrolled into the main 
study, of which 48% (284) identified as homosexual and 
10% (57) as heterosexual.
The mean participant age was 26.91 years (range 18–42, 
SD 6.07). Table 1 compares frequencies for all variables by 
group. At baseline, compared with homosexually identi-
fied MSM, heterosexually identified MSM were less likely 
to have: a greater than high school education (35.09% 
vs 66.55%, p=0.000); ever given oral sex to another man 
(47.37% vs 93.66%, p=0.000); used a condom with their 
most recent female sexual partner (39.13% vs 65.91%, 
p=0.036); anal warts (30.00% vs 68.10% among those with 
visible genital warts, p=0.001); and have  anogenital HPV 
DNA detected (78.95% vs 89.08%, p=0.035). Conversely, 
heterosexually identified MSM were more likely to: iden-
tify as activo (71.43% vs 24.03%, p=0.000); have both male 
and female partners (31.15% vs 2.69%, p<0.000); report 
transactional sex (17.54% vs 5.28%, p<0.001); have used 
drugs during sex in the past month (15.79% vs 3.89%, 
p<0.000); ever smoke cigarettes (92.98% vs 78.29%, 
p<0.010); have used a condom during last anal sex with a 
man (56.14% vs 23.94%, p=0.000); and have penile warts 
(65.00% vs 19.83% among those with visible genital warts, 
p<0.000). There was no difference between the groups in 
HPV knowledge, syphilis or high-risk HPV type prevalence.
In multivariate analysis, none of the biological HPV 
variables were found to have an independent association 
with sexual identity.
dIscussIOn
Heterosexually identified MSM differed significantly 
from homosexually identified MSM in a variety of ways 
related to HPV as well as HIV risk and were more likely to 
report behaviours congruent with behaviourally hetero-
sexual men including having sex with women and being 
less likely to have had (given) oral sex with another man. 
Additionally, the heterosexual men in this study were 
more likely to self-identify as activo, again in line with what 
would be expected from behaviourally heterosexual MSM 
following traditional Latino gender norms. However, an 
activo self-identification was not unanimous for heterosex-
ually identified MSM in this study, with 14% identifying 
as pasivo (receptive) during anal intercourse with other 
men. While it is uncertain how these men conceptualise a 
heterosexual identification with a pasivo role when having 
sex with men, it does not necessarily mean that they are 
‘secretly homosexual or bisexual.’ Rather, it may be that 
these men, like the participants in Carrillo and Hoffman’s 
recent qualitative study of 100 heterosexual-identifying 
MSM in the USA, firmly identify with a heterosexual 
identity, do not wish to be seen otherwise and do not 
see their self-identities changing; it may be that they see 
themselves as ‘heteroflexible’ with ‘elastic sexualities’.27 
Of note, Carrillo’s study sample was not limited to Latinos 
but included other races (ie, White, African American, 
Native American, Asian American and Middle Eastern/
White) which may extend the relevance of the present 
study beyond heterosexually identified Peruvian MSM.
While the presence of anogenital HPV was detected in 
fewer heterosexually identified MSM (78.95%) compared 
with homosexually identified MSM (89.08%), it was still 
markedly higher than for heterosexual men who have sex 
only with women (≤50%16) and comparable to previous 
reports of anogenital HPV DNA prevalence among 
HIV-negative Peruvian MSM.24 25 Men (in general) who 
strongly endorse traditional masculine stereotypes—
perhaps a view shared by the heterosexual MSM in 
this study—are less likely to receive preventive health-
care services compared with men with more moderate 
masculinity beliefs.28 Moreover, when care is accessed, 
lower education coupled with high HPV prevalence may 
increase heterosexually identified MSM’s risk for HIV 
and HPV-associated anogenital cancers because they 
may not know to ask doctors about HPV, HPV vaccina-
tion or HPV-related cancers. Similarly, doctors may not 
consider them at risk for HPV, and therefore not provide 
HPV information or vaccine information.21 Together 
with potentially stigmatising experiences when accessing 
medical attention for genital warts,22 the result is a poten-
tial missed opportunity for education through physician 
contact.
Though we do not know the HPV infection route for 
the heterosexual men with penile warts in our study, they 
or their treating physicians could assume exposure was 
via sex with women, thereby avoiding both the embar-
rassment and shame of being labelled homosexual but 
circumventing an important point of contact where 
additional HPV screening and treatment (eg, for anal 
warts) or HIV or other STI testing could occur. Notably, 
though penile warts were predominant among the 
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Table 1 Characteristics of heterosexually identified (n=57) compared with homosexually identified (n=284) Peruvian men who 
have sex with men
Characteristic
Sexual identity
χ2 p Value
Heterosexual
n (%)*
Homosexual
n (%)*
Age (years)
  18–20 15/57 (26.32) 52/284 (18.31) 0.252
  21–24 19/57 (33.33) 77/284 (27.11)
  25–32 16/57 (28.07) 104/284 (36.62)
  >32 7/57 (12.28) 51/284 (17.96)
Education
  At least secondary 37/57 (64.91) 95/284 (33.45) 0.000
  Higher than secondary 20/57 (35.09) 189/284 (66.55)
Sex role during anal intercourse with men
  Activo 40/56 (71.43) 68/283 (24.03) 0.000
  Moderno 8/56 (14.29) 91/283 (32.16)
  Pasivo 8/56 (14.29) 124/283 (43.82)
Sex of sex partners (previous 6 months)
  Male only 25/41 (60.98) 217/223 (97.31) 0.000
  Male and female 14/41 (31.15) 6/223 (2.69)
  Female only 2/41 (4.88) 0/223 (0)
Transactional sex (ever)
  Yes 10/57 (17.54) 15/284 (5.28) 0.001
  No 47/57 (82.46) 269/284 (94.72)
Drug† use during any sex (past month)
  Yes 9/57 (15.79) 11/283 (3.89) 0.000
  No 48/57 (84.21) 272/283 (96.11)
Alcohol use during any sex (past month)
  Yes 21/57 (36.84) 77/278 (27.70) 0.166
  No 36/57 (63.16) 201/278 (72.30)
Cigarette use (ever)
  Yes 53/57 (92.98) 220/281 (78.29) 0.010
  No 4/57 (7.02) 61/281 (21.71)
Age at first anal intercourse (years)
  <14 8/57 (14.04) 46/284 (16.20) 0.865
  14–19 34/57 (59.65) 171/284 (60.21)
  >19 1557 (26.32) 67/284 (23.59)
Oral sex (giving) to a man (ever)
  Yes 27/57 (47.37) 266/284 (93.66) 0.000
  No 30/57 (52.63) 18/284 (6.34)
Condom during anal intercourse with man (last)
  Yes 32/57 (56.14) 68/284 (23.94) 0.000
  No 25/57 (43.86) 216/284 (76.06)
Condom during any intercourse with woman (last)
  Yes 9/23 (39.13) 29/44 (65.91) 0.036
  No 14/23 (60.87) 15/44 (34.09)
Circumcised
Continued
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Characteristic
Sexual identity
χ2 p Value
Heterosexual
n (%)*
Homosexual
n (%)*
  Yes 2/57 (3.51) 17/284 (5.99) 0.457
  No 55/57 (96.49) 267/284 (94.01)
Syphilis (rapid test)
  Positive 14/57 (24.56) 47/284 (16.55) 0.150
  Negative 43/57 (75.44) 237/284 (83.45)
Had ever heard of HPV (prior to study)
  Yes 21/57 (36.98) 146/281 (51.96) 0.097
  No 36/57 (63.16) 135/281 (48.04)
Anogenital (pooled sample) HPV DNA detected
  Yes 45/57 (78.95) 253/284 (89.08) 0.035
  No 12/57 (21.05) 31/284 (10.92)
Anogenital warts (ever)
  Yes 30/57 (52.63) 166/284 (58.45) 0.417
  No 27/57 (47.37) 118/284 (41.55)
Genital wart location
  Anal 6/20 (30.00) 79/116 (68.10) 0.001
  Penile 13/20 (65.00) 23/116 (19.83) 0.000
  Anal and penile 1/20 (5.00) 9/116 (7.56)
  Testes – 5/116 (4.31)
High-risk HPV (pooled anogenital sample)
  Yes 28/57 (49.12) 153/284 (53.87) 0.512
  No 29/57 (50.88) 131/284 (46.13)
Bold font indicates statistical significance at p<0.05.
*Because of missing data, not all variables sum to the total N.
†Drugs included: cocaine or its derivative (coca básica), marijuana, poppers.
HPV, human papillomavirus.
Table 1 Continued 
heterosexually identified MSM in this study, among those 
with visible anogenital warts, approximately 30% had 
anal warts which could have been missed in a medical 
screening where exclusive vaginal sex with women, and 
not the potential for receptive anal sex with men, may 
have been assumed. Nearly half of the heterosexu-
ally identified MSM had a detectable high-risk (ie, onco-
genic) HPV genotype detected in their pooled anogenital 
sample, a reminder that both groups of men could have, 
and possibly still would, benefit from HPV vaccination.
Important behaviours that could increase HIV/STI 
transmission risks among heterosexually identified MSM 
in this study included: drug use during last anal inter-
course, having had transactional sex and no condom use 
during sex with their most recent female partner. While 
a deeper analysis of these variables was beyond the scope 
of our primary interest in HPV, we hope to stimulate the 
inclusion of sexual identity as an independent variable in 
future HIV/STI research among Latino MSM.
This study is limited by the nature of non-random 
sampling and cross-sectional design, which confines the 
findings to associations rather than causality, and our 
findings cannot be generalised to all Peruvian MSM or all 
Latino MSM. For clarity, we opted to restrict our analyses 
to MSM identifying as only exclusively heterosexual or 
exclusively homosexual. This limited the number of our 
comparison groups, especially the heterosexual group. 
Further, the present analyses were restrained by the 
inherent limitations of performing secondary analyses 
on data sets with differing primary scientific aims. Larger, 
prospective, longitudinal studies specific to sexual iden-
tity and HIV/STI risks could address these methodolog-
ical limitations.
This is the first study, to our knowledge, to compare 
only heterosexually and homosexually identified Latino 
MSM with regard to HPV and other HIV risk factors. 
Though narrow in scope, this study adds to a growing 
body of literature illuminating the diversity of Latino men 
grouped under the MSM umbrella term. Unlike nearly all 
other STIs, a preventive vaccine exists for HPV. Though 
universal, gender neutral HIV vaccination would be ideal, 
we present further evidence that at least Peruvian MSM 
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should be offered access to biomedical interventions that 
can prevent genital warts and associated cancers. Our 
study demonstrates that some HPV-related factors may 
differ between heterosexually identified and homosexu-
ally identified MSM which may require tailored, HPV-spe-
cific interventions.
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